EYES - Latest News

Second Sight Medical Products, Inc. (EYES), operates in Healthcare / Medical - Devices, trades on NASDAQ.

Market capitalization stands near $210.0M. Beta to the broader market is 2.56.

The article list below shows the most recent EYES headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.

Recent EYES Headlines

/C O R R E C T I O N -- Corgi Funds/

prnewswire.com - May 6, 2026

In the news release, Corgi Launches 28 Actively Managed Thematic ETFs on Cboe BZX, issued 06-May-2026 by Corgi Funds over PR Newswire, we are advised

How News Affects EYES Options Pricing

Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track EYES's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.